Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

NorthX Biologics AB

Closing information (x1000 EUR)

Closing information 2023/12 2022/12 2021/12
Turnover 9,868 More Arrow 14,282 Less Arrow 13,548
Financial expenses 19 More Arrow 71 Less Arrow 42
Earnings before taxes -6,647 More Arrow -1,055 Less Arrow -3,113
EBITDA -5,642 More Arrow -390 Less Arrow -2,194
Total assets 32,372 Less Arrow 24,839 Less Arrow 21,653
Current assets 14,989 Less Arrow 12,404 Less Arrow 10,213
Current liabilities 28,188 Less Arrow 24,129 Less Arrow 21,444
Equity capital 4,185 Less Arrow 710 Less Arrow 210
- share capital 9 Equal arrow 9 More Arrow 10
Employees (average) 145 Less Arrow 129 Less Arrow 124

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 12.9% Less Arrow 2.9% Less Arrow 1.0%
Turnover per employee 68 More Arrow 111 Less Arrow 109
Profit as a percentage of turnover -67.4% More Arrow -7.4% Less Arrow -23.0%
Return on assets (ROA) -20.5% More Arrow -4.0% Less Arrow -14.2%
Current ratio 53.2% Less Arrow 51.4% Less Arrow 47.6%
Return on equity (ROE) -158.8% More Arrow -148.6% Less Arrow -1482.4%
Change turnover -4,456 More Arrow 1,832 More Arrow 4,790
Change turnover % -31% More Arrow 15% More Arrow 55%
Chg. No. of employees 16 Less Arrow 5 More Arrow 20
Chg. No. of employees % 12% Less Arrow 4% More Arrow 19%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.